ADMA Biologics (ADMA) News Today $23.80 -0.31 (-1.29%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period ADMA Biologics (NASDAQ:ADMA) Sets New 1-Year High - Here's WhyADMA Biologics (NASDAQ:ADMA) Sets New 52-Week High - Time to Buy?April 30 at 12:16 PM | marketbeat.comADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025April 30 at 7:00 AM | globenewswire.comOxford Asset Management LLP Makes New Investment in ADMA Biologics, Inc. (NASDAQ:ADMA)Oxford Asset Management LLP acquired a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 13,420 shares of the biotechnology company's stock,April 30 at 6:31 AM | marketbeat.comVirtus ETF Advisers LLC Decreases Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Virtus ETF Advisers LLC trimmed its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 38.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 18,728 shares of the biotechnology company's stApril 30 at 6:14 AM | marketbeat.comVoya Investment Management LLC Acquires 292,642 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Voya Investment Management LLC increased its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 46.8% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 918,361 shares of the biotechnology company's stock after buying an additional 292,642 shares dApril 30 at 5:39 AM | marketbeat.comTeachers Retirement System of The State of Kentucky Purchases 19,708 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Teachers Retirement System of The State of Kentucky boosted its position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 37.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 72,100 shares of the biotechnology company's stock after acquiring anApril 30 at 4:49 AM | marketbeat.comTower Research Capital LLC TRC Raises Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Tower Research Capital LLC TRC lifted its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 1,029.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,236 shares of the biotechnology company's stock afterApril 30 at 4:38 AM | marketbeat.comWhy ADMA Biologics, Inc. (ADMA) Surged on MondayApril 29 at 8:30 AM | msn.comADMA Biologics, Inc.: ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement ProcessApril 28 at 11:15 AM | finanznachrichten.deIBD 50's Top Seed, ADMA, Just Rocketed On A New FDA ApprovalApril 28 at 11:15 AM | msn.comADMA Biologics Shares Hit 52-Week High After FDA ApprovalApril 28 at 11:15 AM | marketwatch.comADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement ProcessApril 28 at 7:00 AM | globenewswire.comLord Abbett & CO. LLC Cuts Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Lord Abbett & CO. LLC trimmed its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 28.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,207,277 shares of the biotApril 28 at 6:09 AM | marketbeat.comJump Financial LLC Acquires New Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Jump Financial LLC bought a new position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 23,504 shares of the biotechnology company's stock,April 28 at 4:10 AM | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Holdings Raised by Oberweis Asset Management Inc.Oberweis Asset Management Inc. raised its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 15.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,342,560 shares of the biotechnology coApril 26, 2025 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Purchased by Guggenheim Capital LLCGuggenheim Capital LLC lifted its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 528.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 67,778 shares of the biotechnology comApril 25, 2025 | marketbeat.com23,107 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Bought by XTX Topco LtdXTX Topco Ltd purchased a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 23,107 shares of the biotechnology company's stock, valued at approximately $396,000. OtheApril 25, 2025 | marketbeat.comBarclays PLC Boosts Stake in ADMA Biologics, Inc. (NASDAQ:ADMA)Barclays PLC lifted its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 2.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 541,093 shares of the biotechnology company's stock after acquiring an additionaApril 25, 2025 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Bought by Harvest Investment Services LLCHarvest Investment Services LLC increased its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 40.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 125,867 shares of the biotechnologyApril 24, 2025 | marketbeat.comMassar Capital Management LP Invests $1.28 Million in ADMA Biologics, Inc. (NASDAQ:ADMA)Massar Capital Management LP bought a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 74,339 shares of the biotechnology company's stock, valued at approximately $1,275,0April 24, 2025 | marketbeat.comBI Asset Management Fondsmaeglerselskab A S Invests $1.89 Million in ADMA Biologics, Inc. (NASDAQ:ADMA)BI Asset Management Fondsmaeglerselskab A S acquired a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 110,063 shares of the biotecApril 24, 2025 | marketbeat.comADMA Biologics, Inc. (ADMA): Among Takeover Rumors Hedge Funds Are BuyingApril 23, 2025 | insidermonkey.comIs ADMA Biologics, Inc. (ADMA) the Best Multibagger Stock to Buy According to Billionaires?April 23, 2025 | insidermonkey.comADMA Biologics (NASDAQ:ADMA) Stock Price Down 10.8% - Here's What HappenedADMA Biologics (NASDAQ:ADMA) Stock Price Down 10.8% - Here's WhyApril 23, 2025 | marketbeat.comB Group Inc. Invests $39.23 Million in ADMA Biologics, Inc. (NASDAQ:ADMA)B Group Inc. acquired a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 2,287,542 shares of the biotechnology company's stocApril 23, 2025 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Bank of Montreal CanBank of Montreal Can cut its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 98.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,562 shares of the biotechnology company's stock after sellinApril 23, 2025 | marketbeat.comWells Fargo & Company MN Decreases Stake in ADMA Biologics, Inc. (NASDAQ:ADMA)Wells Fargo & Company MN decreased its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 61.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 250,561 shares of the biotechnology cApril 23, 2025 | marketbeat.comStocks With Rising Relative Strength: BioNTech ADRApril 22, 2025 | msn.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Mesirow Institutional Investment Management Inc.Mesirow Institutional Investment Management Inc. reduced its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 21.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 782,451 shares of the biotechnology company's stockApril 22, 2025 | marketbeat.comRaymond James Financial Inc. Takes $19.08 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Raymond James Financial Inc. acquired a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,112,275 shares ofApril 22, 2025 | marketbeat.comWhy ADMA Biologics Inc. (ADMA) Performed Worst On Monday?April 22, 2025 | msn.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Zacks Investment ManagementZacks Investment Management trimmed its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 11.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 254,662 shares of the biotechnology company's stock after selling 33,347 shareApril 20, 2025 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) is Altium Capital Management LLC's 2nd Largest PositionAltium Capital Management LLC boosted its position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 2.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,395,000 shares of the biotechnology coApril 19, 2025 | marketbeat.comA life sciences and health care hub is growing in the Palm BeachesApril 18, 2025 | bizjournals.comEAM Global Investors LLC Sells 126,820 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)EAM Global Investors LLC lessened its position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 31.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 277,151 shares of the biotechnology company's stock after sApril 18, 2025 | marketbeat.comEAM Investors LLC Reduces Stake in ADMA Biologics, Inc. (NASDAQ:ADMA)EAM Investors LLC lessened its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 13.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 235,813 shares of the biotechnology company's stock afApril 18, 2025 | marketbeat.comLegal & General Group Plc Acquires 139,840 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Legal & General Group Plc increased its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 20.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 836,850 shares of the biotechnology company'sApril 18, 2025 | marketbeat.comInvestors Buy Large Volume of Call Options on ADMA Biologics (NASDAQ:ADMA)ADMA Biologics, Inc. (NASDAQ:ADMA - Get Free Report) saw unusually large options trading activity on Tuesday. Stock investors purchased 7,765 call options on the stock. This is an increase of approximately 178% compared to the average daily volume of 2,789 call options.April 17, 2025 | marketbeat.comADMA Biologics (ADMA): Among Louis Navellier’s New Stock PicksApril 17, 2025 | msn.comADMA Biologics (NASDAQ:ADMA) Shares Gap Up - Time to Buy?ADMA Biologics (NASDAQ:ADMA) Shares Gap Up - What's Next?April 17, 2025 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by LSV Asset ManagementLSV Asset Management trimmed its position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 35.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 80,300 shares of the biotechnology company's stock after selling 43,99April 17, 2025 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Shares Up 8.8% - Here's What HappenedADMA Biologics (NASDAQ:ADMA) Trading 8.8% Higher - Here's What HappenedApril 16, 2025 | marketbeat.comWhy ADMA Biologics, Inc. (ADMA) Skyrocketed On Tuesday?April 16, 2025 | msn.comWhy ADMA Biologics Inc. (ADMA) Skyrocketed On Monday?April 15, 2025 | msn.comKennedy Capital Management LLC Sells 117,157 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Kennedy Capital Management LLC reduced its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 30.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 269,652 shares of the biotechnology cApril 15, 2025 | marketbeat.comTrexquant Investment LP Has $591,000 Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Trexquant Investment LP decreased its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 95.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 34,434 shares of the biotechnology company's stock after selling 788,187April 15, 2025 | marketbeat.comWellington Management Group LLP Has $1.81 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Wellington Management Group LLP reduced its position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 11.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 105,459 shares of the biotechnology company's stock after selling 13,834 shares during the period. WApril 15, 2025 | marketbeat.comAlliancebernstein L.P. Has $4.72 Million Stake in ADMA Biologics, Inc. (NASDAQ:ADMA)Alliancebernstein L.P. raised its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 13.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 275,263 shares of the biotechnology company's stock after buying anApril 15, 2025 | marketbeat.comInvesco Ltd. Sells 1,323,514 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Invesco Ltd. reduced its position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 10.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,296,255 shares of the biotechnology company's stock after selling 1,323,April 14, 2025 | marketbeat.comAviva PLC Makes New $539,000 Investment in ADMA Biologics, Inc. (NASDAQ:ADMA)Aviva PLC purchased a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 31,427 shares of the biotechnology company's stock, valued aApril 14, 2025 | marketbeat.com Get ADMA Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMA and its competitors with MarketBeat's FREE daily newsletter. Email Address ADMA Media Mentions By Week ADMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADMA News Sentiment▼1.240.85▲Average Medical News Sentiment ADMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADMA Articles This Week▼228▲ADMA Articles Average Week Get ADMA Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SMMT News TEVA News ITCI News GMAB News RDY News MRNA News ASND News VTRS News QGEN News ROIV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADMA) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADMA Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ADMA Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADMA Stock Free ADMA Stock Alerts